A trial to learn how baxdrostat affects the heartbeat in healthy participants
D6970C00004
Phase 1 other active
Quick answer
A trial to learn how baxdrostat affects the heartbeat in healthy participants for Treatment-resistant hypertension, Primary aldosteronism, Uncontrolled hypertension is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Treatment-resistant hypertension, Primary aldosteronism, Uncontrolled hypertension
- Phase
- Phase 1
- Modality
- other
- Status
- active